Literature DB >> 16482631

Role of N-acetylcysteine in rifampicin-induced hepatic injury of young rats.

S-V Rana1, S Attri, K Vaiphei, R Pal, A Attri, K Singh.   

Abstract

AIM: To study the role of N-acetylcysteine (NAC) as a protective agent in rifampicin (RMP)-induced oxidative hepatic injury of young rats.
METHODS: Hepatic injury was produced by giving 50 mg/kg body weight/day of RMP for 3 wk. A dose of NAC (100 mg/kg body weight/day) was given in combination with RMP intraperitoneally. Analysis of lipid peroxidation, thiol levels, cytochrome P450, superoxide dismutase (SOD), catalase, glutathione peroxidase, reductase and transferase were estimated in liver along with the body weight, liver weight and histological observations.
RESULTS: RMP exposure resulted in no change in body and liver weight while antioxidative enzymes were altered but the non protein thiol (GSH) status was well preserved. Cytochrome P450 system and peroxidation of lipids were induced by RMP exposure. Partial protection was observed with NAC against RMP-induced changes in liver, which was evidenced from the prevention of increase in lipid peroxidation and the reduction in SOD and catalase enzyme levels.
CONCLUSION: NAC protects young rats against RMP-induced oxidative hepatic injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482631      PMCID: PMC4066040          DOI: 10.3748/wjg.v12.i2.287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Isoniazid- and rifampicin-induced oxidative hepatic injury--protection by N-acetylcysteine.

Authors:  S Attri; S V Rana; K Vaiphei; C P Sodhi; R Katyal; R C Goel; C K Nain; K Singh
Journal:  Hum Exp Toxicol       Date:  2000-09       Impact factor: 2.903

3.  Purification by affinity chromatography of yeast glutathione reductase, the enzyme responsible for the NADPH-dependent reduction of the mixed disulfide of coenzyme A and glutathione.

Authors:  I Carlberg; B Mannervik
Journal:  Biochim Biophys Acta       Date:  1977-10-13

4.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

5.  Acetylhydrazine hepatotoxicity.

Authors:  A K Bahri; C S Chiang; J A Timbrell
Journal:  Toxicol Appl Pharmacol       Date:  1981-09-30       Impact factor: 4.219

6.  Amelioration of hepatocellular integrity and inhibition of sinusoidal oxidative stress by N-acetylcysteine pretreatment in cold ischemia-reperfusion injury of rat liver.

Authors:  H Nakano; K Boudjema; D Jaeck; E Alexandre; P Imbs; M P Chenard; H Nagasaki; K Kumada; P Wolf; J Cinqualbre
Journal:  Eur Surg Res       Date:  1996 Jul-Aug       Impact factor: 1.745

7.  Oxidative-hepatic injury of isoniazid-rifampicin in young rats subjected to protein and energy malnutrition.

Authors:  C P Sodhi; S F Rana; S Attri; S Mehta; K Yaiphei; S K Mehta
Journal:  Drug Chem Toxicol       Date:  1998-08       Impact factor: 3.356

8.  Induction of rat liver bilirubin-conjugating enzymes and glutathione S-transferase by rifampicin.

Authors:  Y Adachi; T Nanno; M Yamashita; S Ueshima; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1985-04

9.  Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals.

Authors:  A Meyer; R Buhl; S Kampf; H Magnussen
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

10.  Effect ofN-acetylcysteine administration on cysteine and glutathione contents in liver and kidney and in perfused liver of intact and diethyl maleate-treated rats.

Authors:  W B Yao; Y Q Zhao; T Abe; J Ohta; T Ubuka
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

View more
  9 in total

1.  Assessment of hepatotoxicity of first-line anti-tuberculosis drugs on Wistar rats.

Authors:  Radhika Sharma; Ramneek Kaur; Manishi Mukesh; Vijay L Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-09       Impact factor: 3.000

2.  A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.

Authors:  Chote Luangchosiri; Ammarin Thakkinstian; Sermsiri Chitphuk; Wasana Stitchantrakul; Supanna Petraksa; Abhasnee Sobhonslidsuk
Journal:  BMC Complement Altern Med       Date:  2015-09-23       Impact factor: 3.659

Review 3.  Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An Overview.

Authors:  Divya Singh; William C Cho; Ghanshyam Upadhyay
Journal:  Front Physiol       Date:  2016-01-26       Impact factor: 4.566

Review 4.  Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine.

Authors:  Kívia Queiroz de Andrade; Fabiana Andréa Moura; John Marques dos Santos; Orlando Roberto Pimentel de Araújo; Juliana Célia de Farias Santos; Marília Oliveira Fonseca Goulart
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

Review 5.  Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics.

Authors:  Christina Cahill; James Joseph Phelan; Joseph Keane
Journal:  Front Cell Infect Microbiol       Date:  2020-09-15       Impact factor: 5.293

6.  Hepatoprotective Effect of Cissus quadrangularis Stem Extract Against Rifampicin-induced Hepatotoxicity in Rats.

Authors:  A H M Viswanatha Swamy; Rucha V Kulkarni; B C Koti; P C Gadad; A H M Thippeswamy; Aparna Gore
Journal:  Indian J Pharm Sci       Date:  2012-03       Impact factor: 0.975

7.  Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.

Authors:  Sude Eminzade; Fikriye Uraz; Fikret V Izzettin
Journal:  Nutr Metab (Lond)       Date:  2008-07-05       Impact factor: 4.169

Review 8.  N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis.

Authors:  Dawit A Ejigu; Solomon M Abay
Journal:  Tuberc Res Treat       Date:  2020-04-30

9.  Amelioration of hepatotoxicity by biocleavable aminothiol chimeras of isoniazid: Design, synthesis, kinetics and pharmacological evaluation.

Authors:  Neha Vithal Bhilare; Suneela Sunil Dhaneshwar; Kakasaheb Ramoo Mahadik
Journal:  World J Hepatol       Date:  2018-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.